|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li M, Zhang W, Wang B, Gao Y, Song Z and
Zheng QC: Ligand-based targeted therapy: A novel strategy for
hepatocellular carcinoma. Int J Nanomedicine. 11:5645–5669. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Forner A, Reig ME, de Lope CR and Bruix J:
Current strategy for staging and treatment: The BCLC update and
future prospects. Semin Liver Dis. 30:61–74. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peters GJ and Honeywell RJ: Drug transport
and metabolism of novel anticancer drugs. Expert Opin Drug Metab
Toxicol. 11:661–663. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Berretta M, Rinaldi L, Di Benedetto F,
Lleshi A, De Re V, Facchini G, De Paoli P and Di Francia R:
Angiogenesis inhibitors for the treatment of hepatocellular
carcinoma. Front Pharmacol. 7:4282016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hanahan D and Folkman J: Patterns and
emerging mechanisms of the angiogenic switch during tumorigenesis.
Cell. 86:353–364. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Di J, Gao K, Qu D, Yang J and Zheng J:
Rap2B promotes angiogenesis via PI3K/AKT/VEGF signaling pathway in
human renal cell carcinoma. Tumour Biol. 39:10104283177016532017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jurenka JS: Anti-inflammatory properties
of curcumin, a major constituent of Curcuma longa: A review of
preclinical and clinical research. Altern Med Rev. 14:141–153.
2009.PubMed/NCBI
|
|
9
|
Jiao D, Wang J, Lu W, Tang X, Chen J, Mou
H and Chen QY: Curcumin inhibited HGF-induced EMT and angiogenesis
through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways
in lung cancer. Mol Ther Oncolytics. 3:160182016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Haryuna TS, Munir D, Maria A and
Bashiruddin J: The antioxidant effect of curcumin on cochlear
fibroblasts in rat models of diabetes mellitus. Iran J
Otorhinolaryngol. 29:197–202. 2017.PubMed/NCBI
|
|
11
|
Zhang CY, Zhang L, Yu HX, Bao JD and Lu
RR: Curcumin inhibits the metastasis of K1 papillary thyroid cancer
cells via modulating E-cadherin and matrix metalloproteinase-9
expression. Biotechnol Lett. 35:995–1000. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin J, Deng H, Jin L, Pandey P, Quinn J,
Cantin S, Rynkiewicz MJ, Gorga JC, Bibbins F, Celatka CA, et al:
Design, synthesis, and biological evaluation of peptidomimetic
inhibitors of factor XIa as novel anticoagulants. J Med Chem.
49:7781–7791. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen WC, Lai YA, Lin YC, Ma JW, Huang LF,
Yang NS, Ho CT, Kuo SC and Way TD: Curcumin suppresses
doxorubicin-induced epithelial-mesenchymal transition via the
inhibition of TGF-β and PI3K/AKT signaling pathways in
triple-negative breast cancer cells. J Agric Food Chem.
61:11817–11824. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Abouzied MM, Eltahir HM, Abdel Aziz MA,
Ahmed NS, Abd El-Ghany AA, Abd El-Aziz EA and Abd El-Aziz HO:
Curcumin ameliorate DENA-induced HCC via modulating TGF-β, AKT, and
caspase-3 expression in experimental rat model. Tumour Biol.
36:1763–1771. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH Image to ImageJ: 25 years of image analysis. Nat Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Whittaker S, Marais R and Zhu AX: The role
of signaling pathways in the development and treatment of
hepatocellular carcinoma. Oncogene. 29:4989–5005. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mogler C, König C, Wieland M, Runge A,
Besemfelder E, Komljenovic D, Longerich T, Schirmacher P and
Augustin HG: Hepatic stellate cells limit hepatocellular carcinoma
progression through the orphan receptor endosialin. EMBO Mol Med.
9:741–749. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu A, Huang JJ, Jin XJ, Li JP, Tang YJ,
Huang XF, Cui HJ, Xu WH and Sun GB: Curcumin suppresses
invasiveness and vasculogenic mimicry of squamous cell carcinoma of
the larynx through the inhibition of JAK-2/STAT-3 signaling
pathway. Am J Cancer Res. 5:278–288. 2014.PubMed/NCBI
|
|
20
|
Zhu AX: Systemic therapy of advanced
hepatocellular carcinoma: How hopeful should we be? Oncologist.
11:790–800. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Farhangi B, Alizadeh AM, Khodayari H,
Khodayari S, Dehghan MJ, Khori V, Heidarzadeh A, Khaniki M,
Sadeghiezadeh M and Najafi F: Protective effects of dendrosomal
curcumin on an animal metastatic breast tumor. Eur J Pharmacol.
758:188–196. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kumar P, Kadakol A, Shasthrula PK, Mundhe
NA, Jamdade VS, Barua CC and Gaikwad AB: Curcumin as an adjuvant to
breast cancer treatment. Anticancer Agents Med Chem. 15:647–656.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Z, Dabrosin C, Yin X, Fuster MM,
Arreola A, Rathmell WK, Generali D, Nagaraju GP, El-Rayes B,
Ribatti D, et al: Broad targeting of angiogenesis for cancer
prevention and therapy. Semin Cancer Biol. 35 Suppl:S224–S243.
2015. View Article : Google Scholar : PubMed/NCBI
|
